In summary, our study indicates that the down-regulation of PTEN expression in CLL is related to the aberrant expression of miR-26a and miR-214, especially miR-26a, but not PTEN mutations or promoter methylation. The gene discussed is PTEN; the disease is B-cell chronic lymphocytic leukemia.